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1. Introduction
  Now it is reported that multi-gene, multi-stage 
interaction of oncogenes activation or tumor-suppressor 
gene inactivation constitute the molecular basis of the 
development of hepatocellular carcinoma. It is also reported 
that Pokemon (POK family of transcriptional repressors) 
as a cancer gene may be located upstream, and plays a 
key role in malignant transformation[1-4]. In some human 
tumors such as lymphoma, breast, lung, colon, prostate and 
bladder cancer, Pokemon is highly expressed. Pokemon not 
only plays a role in the embryonic development and cell 
differentiation, and cooperates with other classic oncogenes 
as a proto-oncogene[5-13]. The detailed mechanism and 
function of Pokemon in hepatocellular carcinoma are still 
unclear. Maeda et al[1,2]reported that pokemon can inhibit 
transcription of P14ARF, regulate cell cycle and induce 
tumors, but at the same time pokemon may regulate other 
target genes to inhibit tumor cell apoptosis. 
 The occurrence and development of hepatocellular 
carcinoma are associated with the imbalances of 
proliferation and apoptosis in hepatocellular carcinoma 
cell. The changes of nuclear factor-毷B (NF-毷B) and Bcl-2 
gene are more important in this imbalances. NF-毷B is a 
nuclear transcription factor which exists in a variety of cells 
in the body, and play an important role in carcinogenesis 
and apoptosis. Current studies have shown that, NF- 毷B 
signal transduction pathways is involved in oncogenes and 
tumor suppressor gene transcription may be involved in 
apoptosis by inhibiting the development of hepatocellular 
carcinoma[14-16]. Bcl-2 is a proto-oncogene. The proteins of 
the Bcl-2 family are important regulators of apoptosis under 
normal and pathological conditions. The protein encoded 
by Bcl-2 proto-oncogene is implicated in the prolongation 
of cell survival by blocking programmed cell death, i.e. 
apoptosis[17]. Expression of apoptosis related gene Bcl-2 
and NF-毷B gene are important adjustment factors in the 
incidence and development of hepatocellular carcinoma[18].
Objective: To investigate the relationship among Pokemon, NF-毷B p65 and Bcl-2 in hepatoma 
cells. Methods: HCC cell HepG2, SMMC7721 and human fetal liver cell line LO2 cells were 
used, and expression of Pokemon, NF-毷B p65 and Bcl-2 in three cells were detected by real-
time PCR and western blot. Then siRNA of Pokemon was applied to inhibit the expression 
of Pokemon and NF-毷B p65 and apoptotic rate was determined by flow cytometric analysis. 
Results: Expressions of Pokemon, NF-毷B p65 and Bcl-2 in human hepatoma cell HepG2, 
SMMC7721 expression were significantly higher than those in human embryonic stem cells LO2. 
siRNA of Pokemon inhibited the expression of Pokemon, NF-毷B p65 and Bcl-2 in liver cancer 
cells, and significantly increased apoptosis of liver cells. While siRNA of NF-毷B p65 inhibited 
the expression of NF-毷B p65 and Bcl-2, but Pokemon expression in hepatoma cells had no 
significant change. Conclusions: The proto-oncogene Pokemon can inhibit P14ARF by specific 
transcription regulation of cell cycle and can induce tumors. In addition, Pokemon can regulate 
NF-毷B p65 through the expression of apoptosis repressor, and promote the development of liver 
cancer. It suggests signal network in the liver include the regulation of new non-classical NF-毷
B regulatory pathway.
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  POK proteins are known to recruit corepressor complexes 
through the POZ domain, so we hypothesized that Pokemon 
might exert its oncogenic activity through the direct 
repression of potent tumor suppressor or apoptotic genes. 
NF-毷B p65 is a very important transcription factor, and 
can mediate apoptosis process. Concerning the structure 
of Pokemon POZ protein and that signaling pathways may 
be involved in NF-毷B signaling pathway, we explore the 
relationship and the signal pathway mechanism of pokemon, 
NF-毷B and Bcl-2 in this study.    
2. Materials and  Methods
2.1. Culture
  The human HCC cell line HepG2, SMMC7721 and the 
human fetal liver cell line LO2 were from the Cell Bank of 
Type Culture Collection of Chinese Academy of Sciences, 
Shanghai Institutes for Biological Sciences. They were 
maintained routinely in RPMI 1640 medium supplemented 
with 10% fetal bovine serum (FBS) and cultured at 37 曟 in 
a humidified incubator containing 5% CO2. The cells were 
subcultured once every three days.  
2.2. RNA isolation and real time PCR
  RNA was prepared with TRIzol ® (Invitrogen, CA, USA). 
One microgram of total RNA was heated at 70 ℃ for 5 min. 
and placed on ice for 5 min. A mix of 5 毺L M-MLV RT 5伊 
reaction buffer, 10 mM of each of the four dNTPs, 200 U of 
M-MLV transcriptase enzyme(H-), 25 pg/毺L of oligo (dT) 
primer and 20 U of RNase inhibitor (all from Promega, WI, 
USA) were added to each sample, followed by incubation 
at 40 ℃ for 60 min and 70 ℃ for 15 min. Real-time PCR 
was performed using double stranded DNA dye SYBR Green 
PCR Master Mix (PE Biosystems, Warrington, UK) on the 
ABI PRISM 7700 system (Perkin-Elmer, CA,USA). PCRs were 
performed in triplicate and GAPDH was co-amplified to 
normalize the amount of RNA. All data were analyzed by 
the ABI PRISM SDS 2.0 software. Primer sequences were as 
following, Pokemon: Sense 5’ AGCCCTACGAGTGCAACATC 
3’  and antisense 5’  CAGCCGTCTTTCTTGAGGTG 3’ , 
GAPDH: Sense 5’ CACGAAACTACCTTCAACTCC 3’ and 
antisense 5’  CATACTCCTGCTTGCTGATC 3’ ;  Bcl-2：
Sense 5’ CTGGTGGACAACATCGCTCTG 3’ and antisense 
5 ’  GGTCTGCTGACCTCACTTGTG 3 ’ ,  GAPDH:  Sense 
5 ’  GGGAAATCGTGCGTGACAT 3 ’  and  ant i sense  5 ’ 
CAGGAGAGCAATGATCATT 3’. To compare the expression of 
mRNA  in different samples, the relative expression of mRNA 
was calculated using the comparative delta CT (threshold 
cycle number) method as described by Yague et al[19]. 
Briefly, the following formula was used:2-荭荭CT，where 荭
CT is the difference in CT between the gene of interest and 
GAPDH, and 荭荭CT for the sample =荭CT  for the actual 
sample－2-荭荭CT of the lowest expression sample[20].
2.3. Western blot analysis
  Nuclear and cytoplasmic proteins were extracted from 
HepG2, SMMC7721 and LO2 cells using the NE-PER® 
nuclear and cytoplasmic extraction kit (PIERCE) according 
to the protocol. For the whole cell extracts, cells were lysed 
in RIPA extraction buffer (150 mM sodium chloride, 50 mM 
Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid,
1 mM PMSF, 1% Triton 伊-100, 1% sodium deoxycholate, 
0.1% SDS, 5 mg/mL aprotinin and 5 mg/mL leupeptin) and 
were then centrifuged. The supernatant was used as the 
whole cell protein extract.
  A total of 40 毺g extracts were separated by 10% SDS-
PAGE. Proteins were transferred to an Immun-Blot® 
polyvinylidene difluoride membrane (Bio-Rad) and 
blocked for 1 h with 5% skim milk. Blotted membranes 
were incubated with various primary antibodies, which were 
diluted by 1:2 000, followed by horseradish peroxidase-
conjugated mouse or goat IgG. Protein bands were visualized 
with ECL solution (PerkinElmer Life Sciences).
2.4. Down-regulation of Pokemon and NF- 毷B p65 by 
siRNA
  The small interfering RNA (siRNA) of Pokemon (siRNA: 5’ 
–GCUGGACCUUGUAGAUCAA-3’, from Health Industry Co., 
Ltd. Shanghai) was used to examine the role of Pokemon in 
mediating the antiapoptosis. Firstly, cells were transfected 
in HepG2 or SMMC7721 cells in logarithmic phase of 3.0 伊 106 
cells/well in 6-well plate shop, until 80%-90% cell fusion. 
A total of 10 毺L of Lipofectamine 2000 and plasmid were 
added to 250 毺L of OPTI-MEM, mixed, and incubated at 
room temperature after 30 min. After incubation for 4 h, the 
mixture was added to each hole containing 10% fetal calf 
serum culture medium, 37 ℃, 5% CO2. After transfection 
for 48 h, total Pokemon protein was extracted and detected 
by Western blot method. The NF-毷B p65 siRNA (siRNA; 
GCCCUAUCCCUUUACGUCA, from Thermo Scientific 
Dharmacon, Lafayette, CO, U.S.A.) was used to examine the 
role of NF-毷 B p65 in mediating the antiapoptosis [21]. Total 
cellular proteins and relative levels of NF-毷B p65 were 
measured by Western blot analysis as described above after 
24 h.
2.5. Flow cytometric analysis
  Cells in logarithmic growth phase of 3 伊 105/well in 6-well 
plate were inoculated until 80%-90% cell confluence. Then 
the trypsin digestion cells were collected. Cells were washed 
by PBS 3 times, 10 毺L of Annexin V from light were added 
and mixed for 30 min, then 5 毺L of PI were added for 
detection by flow cytometry.
2.6. Statistical analysis
  With SPPS 11.0 (SPPS Inc., Chicago, IL) software, statistical 
comparisons between experimental groups were analyzed by 
one-way ANOVA. If there was a significant difference among 
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groups, S-N-K test was used as a post-hoc analysis. Results 
were expressed as mean依SD. Statistical significance was 
assumed if P<0.05.
3. Results
3.1. Pokemon, NF-毷B p65, Bcl-2 expression in three types 
of cells
  Real-time PCR showed that the relative mRNA levels (2-荭
荭CT) of Pokemon in HepG2(1.87依0.11), SMMC7721(1.90依0.13) 
were significantly higher than that of LO2 cells (0.25依0.04)
(P<0.05). The mRNA levels of Pokemon increased slightly 
in HepG2 as compared with group SMMC7721, but there 
was no statistical difference. Western blot showed that the 
expression of Pokemon protein in HepG2, SMMC7721 were 
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Figure 1. Expression of Pokemon protein in three cells. 
* P<0.05, LO2 cells vs. the other groups.
  To determine whether NF-毷B p65 was activated, the level 
of NF-毷B p65 in nucleus was measured. Western blot 
analysis showed that the expression of NF-毷B p65 was 
significantly higher in HepG2 and SMMC7721 than that of 
LO2 cells (P<0.05) (Figure 2).























Figure 2. Expression of NF-毷B p65 proteins in three cells. 
* P<0.05, LO2 cells vs. the other groups.
  Real-time PCR showed that the relative mRNA levels (2-荭
荭CT ) of Bcl-2 in HepG2(8.23依0.75), SMMC7721(8.65依0.82) 
were significantly higher than that of LO2 cells (0.59依0.13) 
(P<0.05). The mRNA levels of Bcl-2 increased slightly in 
SMMC7721 as compared with HepG2 group, but there was no 
statistical difference. While the expression of Bcl-2 protein 
in HepG2, SMMC7721 were significantly higher than that of 
LO2 cells (Figure 3) (P <0.05).























Figure 3. Expression of Bcl-2 proteins in three cells. 
* P<0.05, LO2 cells vs. the other groups.
3.2. Expression of NF-毷B p65, Bcl-2 and apoptosis rate 
after transfection of Pokemon siRNA
  The result showed proteins of Pokemon, NF-毷B p65 and 
Bcl-2 were significantly reduced after 48 h transfection in 
HepG2 and SMMC7721 (P<0.05).(Figure 4,5,6). Relative 
mRNA levels (2-荭荭CT ) of Bcl-2 in HepG2 and SMMC7721 were 
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荭*
Figure 4. Expression of Pokemon protein after transfection of 
Pokemon siRNA. 
* P<0.05, A vs. C groups;荭P<0.05 B vs. D groups; A: HepG2 
untransfected group; B: SMMC7721 untransfected group; C: HepG2 
transfection group; D: SMMC7721 transfected group.






















A                         B                       C                          D
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Figure 5. Expression of NF-毷B p65 after transfection of Pokemon 
siRNA. 
* P<0.05, A vs. C groups;荭P<0.05 B vs. D groups; A: HepG2 
untransfected group; B: SMMC7721 untransfected group; C: HepG2 
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Figure 6. Expression of Bcl-2 protein after transfection of Pokemon 
siRNA. 
* P<0.05, A vs. C groups;荭P<0.05 B vs. D groups; A: HepG2 
untransfected group; B: SMMC7721 untransfected group; C: HepG2 
transfection group; D: SMMC7721 transfected group.
  The apoptosis rate of siRNA Pokemon transfected cells 
significantly increased after 48 h  [(5.07依0.46)% vs. (39.65依
3.75)%; (5.71依0.83)% vs. (33.21依3.66)%] (P<0.05). Between 
negative control cells, there was no significant difference in 
apoptosis rate [(39.65依3.75)% vs. (33.21依3.66)%] (P> 0.05).
3.3. Expression of Pokemon, Bcl-2 and the apoptosis rate 
after transfection of NF-毷B p65 siRNA
  In order to further reveal the relationships among 
Pokemon, NF-毷B p65 and Bcl-2, we apply the method of 
siRNA to reduced the expression of NF-毷B p65. The result 
showed NF-毷B p65 protein was significantly reduced after 
72 h transfection in HepG2 and SMMC7721 (P <0.05).( Figure 
7). After application of NF-毷B p65 siRNA, there was no 
significant difference in relative mRNA levels (2-ΔΔCT) of 
Pokemon in HepG2 and SMMC7721 (P> 0.05)(1.86依0.12 vs. 
1.90±0.13;1.91依0.11 vs. 1.85依0.11). Result of Western blot 
showed Pokemon protein also had no significant difference 
in expression level (P>0.05) (Figure 8). Relative mRNA levels 
(2-ΔΔCT) of Bcl-2 in HepG2, SMMC7721 were significantly 
decreased (P<0.05)(8.70依0.76 vs. 5.15依0.49; 8.29依0.69 vs. 
4.96依0.51). And expression of Bcl-2 protein also decreased 
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Figure 7. Expression of NF-毷B p65 after transfection of NF-毷B 
p65 siRNA. 
* P<0.05, A vs. C groups;荭P<0.05 B vs. D groups; A: HepG2 
untransfected group; B: SMMC7721 untransfected group; C: HepG2 
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* 荭
Figure 8. Expression of Pokemon protein after transfection of NF-毷
B p65 siRNA. 
* P<0.05, A vs. C groups;荭P<0.05 B vs. D groups; A: HepG2 
untransfected group; B: SMMC7721 untransfected group; C: HepG2 
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Figure 9. Expression of Bcl-2 protein after transfection of NF-毷B 
p65 siRNA.
* P<0.05, A vs. C groups;荭P<0.05 B vs. D groups; A: HepG2 
untransfected group; B: SMMC7721 untransfected group; C: HepG2 
transfection group; D: SMMC7721 transfected group.
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  The apoptosis rate of NF-毷B p65 siRNA transfected cells 
significantly increased apoptosis after 72 h (P<0.05) [(5.12依
0.61)% vs. (37.87依4.10)%; (5.80依0.71)% vs. (40.19依3.78)%]. 
While there was no significant difference in apoptosis rate 
of negative control cells (P> 0.05) [(37.87依4.10)% vs. (40.19依
3.78)%].
4. Discussion
  Hepatocellular carcinoma (HCC) is one of the world’s top 
ten malignant tumors, ranking fourth in the incidence of 
malignant tumors, primary liver cancer in China ranks 
second in cancer mortality. Present study suggests that: the 
occurrence and development of HCC more genes involved in 
vivo, the complex multi-step collaborative process, and its 
pathogenesis is still not fully understood.
  We know some of hepatitis virus infection and liver 
cancer-specific carcinogens are the main external factor; 
but, like liver cancer and other malignancies, the occurrence 
and development is also involved in multiple genes in vivo, 
the complex process of synergy.
  So far, studies have shown that liver cancer cells in more 
than 20 abnormal expression of genes such as ras, c-myc, 
c-fos, c-jun, rho, TGFa and so on, these gene mutations, 
loss of heterozygosity, methylation the change of status or 
the abnormal expression of their protein products involved 
in tumor cell signal transduction and cell cycle progression 
abnormal, leading to malignant proliferation of tumor cells. 
So they change at the genetic level and the cumulative 
effects of the interaction between them possible synergy, and 
jointly promote tumor development. However, these genetic 
changes are common in addition to other tumors outside 
the liver, therefore, to find in the liver-specific expression 
of genes and their function in cancer has always been our 
unremitting efforts.
  Pokemon is overexpressed in many human cancers 
and cells lacking Pokemon are refractory to oncogenic 
transformation. Pokemon mediates the development 
of tumors through the ARF-p53 pathway[1,2]. Maeda[2] 
discovered that Pokemon directly binds the p14 AFR 
promoter in vivo and is able to repress its activity. In 
the absence of Pokemon, p14AFR expression was found 
markedly elevated upon both culture shock and oncogenic 
transformation. Pokemon has multiple additional target 
genes by which it can exert its oncogenic activity. NF-毷B is 
a multi-directional, multi-functional nuclear transcription 
factor, and can regulate cell apoptosis and proliferation 
related genes in the cells, which play an important role in 
carcinogenesis[22,23]. NF-毷B protein family consists of 5 
different subunits, of which the most common heterodimer is 
p50/p65[24]. NF-毷B is abnormally activated in hepatocellular 
carcinoma. It can inhibit apoptosis, and promote liver 
cell survival, which is closely related to the development 
of hepatocellular carcinoma[25]. Bcl-2 is an apoptosis 
suppressor gene in human tumors. It inhibits apoptosis by 
inhibition of apoptotic stimuli, which has an important role 
in the occurrence of hepatocellular carcinoma.
  This study is to investigate the relationship among 
Pokemon, NF-毷B and Bcl-2.
  First, we examined Pokemon, NF-毷B and Bcl-2 in the 
hepatoma cells or human fetal liver cells, and found they 
were expressed significantly higher in hepatocellular 
carcinoma cell lines (HepG2, SMMC 7721) than in human fetal 
liver cells. This is consistent with the findings at home and 
abroad. In order to further reveal the relationships among 
Pokemon, NF-毷B p65 and Bcl-2, we apply the method of 
siRNA to reduced the expression of Pokemon. We found 
reduced expression of Pokemon can significantly increased 
apoptosis of hepatoma cells. We also found that NF-毷B p65, 
BCL -2 expressions significantly decreased in HCC cells, 
which suggested Pokemon affect NF-毷B p65 and Bcl-2, and 
there may be a regulatory mechanism. 
  Next, we applied siRNA to reduce the expression of NF-
毷B p65, the results showed that transfection p65siRNA 
blocked NF-毷B signaling pathway, and significantly 
increased apoptosis rate of hepatoma cells. It can not 
affect the expression of Pokemon, but Bcl-2 expression was 
significantly reduced in the experimental group. These 
results showed that in the development of hepatocellular 
carcinoma, oncogene Pokemon regulates NF-毷B, then NF-
毷B regulates Bcl-2 and inhibits apoptosis, which plays 
an important role in the occurrence and development of 
hepatocellular carcinoma.
  Our study reveals Pokemon is the upstream of NF-毷B gene 
and NF-毷B is the upstream regulator of Bcl-2.
  Lee[26] found that the POZ domain of Pokemon interacted 
with the Rel homology domain of the p65 subunit of NF-
毷B in both in vivo and in vitro protein-protein interaction 
assays. Our results show Pokemon can affect the expression 
of NF-毷B. Therefore, we resume that Pokemon may be 
an important regulatory factor of NF-毷B p65. Pokemon 
can participate in the occurrence and development of 
hepatocellular carcinoma by regulating the expression of 
NF-毷B.
  A large number of studies have suggested NF-毷B and 
Bcl-2 may have a synergistic effect in promoting the 
formation of hepatocellular carcinoma[27,28]. Our experiments 
showed that when p65siRNA blocks NF-毷B signaling 
pathway in hepatocellular carcinoma cells, Bcl-2 expression 
is decreased and apoptosis rate is increased. Therefore, we 
conclude that Bcl-2 gene is downstream gene of NF-毷B 
gene. 
  In conclusion, this study suggests that there is a new non-
classical NF-毷B regulatory pathway in the regulation of 
hepatocellular carcinoma signaling networks. We think 
pokemon is a new regulatory factor of NF-毷B, and plays 
a unique role during the development of hepatocellular 
carcinoma. This is a new discovery and supplement of 
the regulatory mechanism in NF-毷B pathway. Also this 
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is helpful to further elucidate molecular mechanism of 
hepatocellular carcinoma.
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